No. Isotretinoin is classified as a Prescription Only Medicine (POM) in the UK and cannot be legally supplied without a valid prescription issued by an authorised healthcare professional. Despite online offers to buy, purchase or order isotretinoin cheap and fast without prescription, patients must follow legal and medical guidelines to ensure safe and appropriate use.
The UK divides medicines into three main categories: Prescription Only Medicine (POM), Pharmacy medicine (P) and General Sales List (GSL). POM drugs like isotretinoin require a prescription because of their potential for serious side effects, the need for specialist monitoring and controlled distribution. Pharmacy medicines can be supplied without prescription under the supervision of a pharmacist, while GSL medicines can be sold freely in retail outlets.
Isotretinoin is a potent retinoid derivative of vitamin A used primarily for severe and treatment-resistant acne, including nodular, cystic and conglobate forms. It is marketed under various brand names and generic forms.
Retinoids are compounds structurally related to vitamin A that regulate cell proliferation, differentiation and apoptosis. In dermatology, they play a key role in normalising skin cell turnover and reducing sebum production.
The pharmacologically active substance is isotretinoin (13-cis retinoic acid). Generic products contain the same molecular entity at specified strengths but may vary in excipients, capsule shell and packaging.
By reducing oil gland size and sebum output, normalising epithelial cell shedding and exhibiting anti-inflammatory properties, isotretinoin targets the underlying mechanisms of acne. It can produce long-lasting remissions in many patients with severe lesions.
No. Unlike oral antibiotics used in acne (e.g., tetracycline or erythromycin), isotretinoin does not act by killing bacteria. Its primary effects are on skin cell behaviour and glandular activity.
While highly effective, isotretinoin is associated with a teratogenic risk, mental health considerations and laboratory abnormalities. Strict prescribing guidelines, including pregnancy prevention programs, are in place to ensure patient safety.
Isotretinoin binds to nuclear retinoic acid receptors and modulates gene expression. The result is decreased sebaceous gland size, reduced sebum excretion, altered keratinisation of follicular epithelium and reduced inflammation in acne lesions.
Some patients notice reduced oiliness and fewer new lesions within two to four weeks. Full therapeutic effect typically emerges over several months of continuous treatment.
Off-label uses include treatment of recalcitrant rosacea, psoriasis, keratinisation disorders and certain cancers under specialist supervision. Any non-acne indication requires careful medical assessment and monitoring.
By reducing severe inflammatory lesions and nodules, isotretinoin can lower the risk of permanent scarring. Its anti-inflammatory effects also contribute to reduced tissue damage during flares.
A minority of patients may experience recurrence of acne after completing a standard course. In such cases, a second course or maintenance therapy under medical supervision may be considered.
Prices vary by strength, brand or generic status, pack size and retailer. For current purchase price and best deals on generic isotretinoin, contact Ivybridge Pharmacy or check online. Fast delivery and competitive pricing are available for valid prescriptions.
Price differences reflect manufacturing costs, patent status, market competition, bulk discounts, pharmacy mark-up and promotional offers. A lower price for generic isotretinoin does not imply reduced quality or efficacy.
| Example | Strength | Formulation | Price | Status | Note |
|---|---|---|---|---|---|
| Accutane® | 20 mg | Oral capsules | Not stated | Brand POM | Prescription required |
| Generic A | 10 mg | Soft gel capsules | Not stated | Generic POM | Cheaper generic alternative |
Standard oral formulations include 10 mg, 20 mg, 30 mg and 40 mg capsules. Dosing is individualised by body weight and severity of acne and may require dose adjustments during therapy.
Most UK products are soft gel capsules in blister packs or bottles. Specialty formulations may include extended-release microsphere capsules. There is no OTC form of isotretinoin.
Pack sizes correspond to treatment duration. For a typical 16–24 week course, multiple packs may be dispensed. The prescribing physician determines the total quantity based on target cumulative dose.
| Feature | Why it matters |
| Strength | Guides daily dose calculation |
| Formulation | Affects bioavailability and tolerability |
| Pack size | Determines treatment course length |
| Brand vs generic | May affect price but not active ingredient |
| Legal category | Prescription only |
Generic isotretinoin must meet regulatory standards for bioequivalence to branded reference products. Differences may exist in capsule shell, excipients and packaging, but the active ingredient and therapeutic effect are equivalent when properly authorised.
Nodular acne features large, firm, inflammatory nodules deep in the skin. Cystic acne involves pus-filled lesions that may coalesce, leading to discomfort and potential scarring.
Adults and adolescents with severe recalcitrant nodular acne, moderate acne unresponsive to antibiotics or acne causing physical or psychological scarring may be considered. Treatment should follow specialist dermatology guidelines.
No. For mild to moderate acne, topical treatments, antibiotics or hormonal therapies are preferred. Isotretinoin is reserved for severe or resistant cases due to its risk profile.
Yes, but careful pregnancy prevention measures are mandatory. Women of childbearing potential must use effective contraception before, during and after treatment, as isotretinoin is highly teratogenic.
Regular blood tests (lipids, liver function) and pregnancy tests for women of childbearing potential are required. Clinical review ensures dose adjustments and detection of adverse effects.
Prescription Only Medicine status means isotretinoin can only be supplied under a prescription from a qualified prescriber. This ensures patient safety through appropriate assessment and monitoring.
Because of its significant risks (teratogenicity, laboratory abnormalities, potential psychiatric effects), it requires direct clinical oversight rather than over-the-counter supply.
The Medicines and Healthcare products Regulatory Agency (MHRA) oversees classification and ensures medicines like isotretinoin have appropriate prescribing restrictions and safety measures.
Regulatory bodies can reclassify medicines based on new safety data, but isotretinoin’s risk profile makes reclassification to OTC highly unlikely without major formulation changes and risk mitigation strategies.
When acne is severe or resistant to other modalities, isotretinoin offers high rates of long-term clearance and reduced scarring compared with repeated antibiotic courses.
Oral antibiotics reduce bacterial colonization and inflammation but often lead to relapse after discontinuation. Isotretinoin addresses multiple pathogenic factors and can induce prolonged remission.
Topical retinoids are effective for comedonal acne and mild inflammatory lesions but have limited efficacy in severe nodular or cystic acne. Isotretinoin’s systemic action reaches deep lesions and glands.
| Feature | Isotretinoin | Oral antibiotics | Topical retinoids |
| Main mechanism | Sebum reduction, normalises keratinisation | Antibacterial, anti-inflammatory | Normalises keratinisation, comedolytic |
| Indication | Severe nodular/cystic acne | Moderate inflammatory acne | Mild to moderate comedonal acne |
| Duration | 16–24 weeks typical | 6–12 weeks or longer | Continuous long-term |
| Side effects | Systemic, teratogenic | Gastrointestinal, photosensitivity | Local skin irritation |
No. Choice depends on acne severity, patient factors, previous response, risk tolerance and specialist guidance.
Certain high-glycaemic foods and dairy products have been implicated in acne flares in some individuals. A balanced diet and hydration are recommended, though evidence varies.
Alcohol may exacerbate liver enzyme elevations and dehydration. Patients should limit alcohol intake during treatment and monitor liver function tests as advised.
Isotretinoin can increase skin sensitivity to ultraviolet light. Use broad-spectrum sun protection and avoid excessive sunbathing or tanning beds.
Strenuous exercise may increase risk of musculoskeletal discomfort. Patients should stay hydrated and adjust activity levels if experiencing joint or muscle pain.
Yes. Nearly all users experience mucocutaneous dryness (lips, skin), and some may develop headaches, mood changes or laboratory abnormalities. Severity varies between individuals.
| Area | Examples described in product information |
| Skin and mucous membranes | Cheilitis, dry skin, eczema-like rash |
| Musculoskeletal | Myalgia, arthralgia, back pain |
| Nervous system | Headache, mood alterations, depression risk |
| Gastrointestinal | Pancreatitis (rare), liver enzyme elevation |
| Vision and hearing | Night vision disturbances, tinnitus (rare) |
Some patients report depressive symptoms or mood swings. Any new or worsening psychiatric symptoms require immediate medical evaluation and possible discontinuation.
Baseline and periodic checks of liver function tests, lipids and complete blood count help detect early adverse effects and guide dose adjustments.
Isotretinoin is highly teratogenic and can cause severe congenital malformations. Strict adherence to pregnancy prevention programs is mandatory.
The standard course is 16–24 weeks to reach a cumulative dose associated with durable remission. Prolonged exposure increases risk of toxicity without additional benefit.
Occasionally, a second course may be prescribed if relapse occurs. Total lifetime exposure should be minimised, and cumulative dose monitored to balance efficacy and safety.
High cumulative doses can amplify dry skin complications, dyslipidaemia and liver dysfunction. Oversight by a dermatologist and regular blood tests mitigate these risks.
Even brief exposure during embryogenesis can result in severe birth defects. Women of childbearing potential must use two forms of contraception and undergo regular pregnancy testing.
Yes. Concomitant use of tetracyclines increases risk of benign intracranial hypertension. Vitamin A supplements amplify toxicity. CYP inducers may alter isotretinoin metabolism.
Both isotretinoin and vitamin A are teratogenic and hepatotoxic. Combined use significantly raises the risk of central nervous system pressure and liver damage.
Procedures like waxing, dermabrasion or laser resurfacing can cause skin fragility and poor healing while on isotretinoin. They are contraindicated during and shortly after therapy.
Suppressing acne can mask emerging signs of serious adverse reactions. Early reporting ensures timely intervention and reduces complication risk.
No. Isotretinoin passes into breast milk and can harm the nursing infant. Breastfeeding must be avoided during and for a specified period after treatment.
A generic formulation contains the same active molecule as the reference brand and must demonstrate bioequivalence. Inactive ingredients and capsule appearance may differ.
Each licensed product has a Summary of Product Characteristics and patient leaflet tailored to its specific formulation, dosage regimen, storage conditions and legal classification.
UK regulations mandate enrolment in a pregnancy prevention plan with regular pregnancy testing, contraceptive counselling and informed consent to minimise teratogenic risk.
Authoritative sources include the MHRA website, the electronic Medicines Compendium (eMC), official patient leaflets and qualified healthcare professionals.
No. This page offers general information only. For personalised advice, prescription and monitoring, please contact the pharmacy team at Ivybridge Pharmacy, 7 Erme Court, Ivybridge, Devon PL21 0SZ.